Company / Current Liabilities per Share
NovaBay Pharmaceuticals, Inc. Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.58
FY2024
5-year range
$0.08 / $2.09
FY2020-FY2024
Trend
+52.8%
vs FY2023
Sector context
#149 of 212
Health Care
What the data says
At $0.58, NovaBay Pharmaceuticals, Inc.'s current liabilities per share ranks #64 of 212 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.08 in FY2021 to $2.24 in FY2015.
Based on SEC 10-K filings.
0.58 in FY2024 with a 5-year CAGR of +17.2%.
Improved from $2.09 to $0.58 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +94.7%
- 5-Year CAGR
- +17.2%
- 10-Year CAGR
- -
Sector benchmark
-96.3% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 52.8% year-over-year.
- Ranks #149 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2015.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.58 | +52.8% |
| FY2023 | $0.38 | -81.8% |
| FY2022 | $2.09 | +2553.3% |
| FY2021 | $0.08 | -2.4% |
| FY2020 | $0.08 | -69.3% |
| FY2019 | $0.26 | +16.5% |
| FY2018 | $0.23 | -30.8% |
| FY2017 | $0.33 | -73.7% |
| FY2016 | $1.24 | -44.7% |
| FY2015 | $2.24 | +2891.6% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026